- Company
- Products
- Catalogs
- News & Trends
- Exhibitions
Breast cancer test kit GenesWell BCToncologyfor genesclinical
Add to favorites
Compare this product
Characteristics
- Pathology
- for breast cancer
- Application domain
- oncology
- Tested parameter
- for genes
- Sample type
- clinical, FFPE tissues
- Analysis mode
- for RT-PCR, for real-time PCR
Description
Multigene prognostic test predicts the probability of metastasis or recurrence, which helps patients make treatment decision. It improves quality of life for cancer patients as preventing them from unnecessary chemotherapy.
GenesWell BCT predicts probability of distant metastasis and chemobenefit within 10 years after surgery.
Extract RNA from tumor tissue
Analyze expression level of prognostic genesrelated in breast cancer
Calculate risk using GenesWell BCT Algorithm
Provide results of risk classification and probability of distantmetastasis
VIDEO
Catalogs
GenesWell BCT Patient Guide
8 Pages
GenesWell BCT Leaflet
2 Pages
Related Searches
- Assay kit
- Blood assay kit
- Plasma assay kit
- Infectious disease assay kit
- Molecular test kit
- Whole blood detection kit
- Clinical assay kit
- Real-time PCR test kit
- Tumour detection test kit
- Genetic test kit
- Tissue detection kit
- PCR assay kit
- RT-PCR detection kit
- Nucleic acid assay kit
- Genetic mutation detection kit
- DNA assay kit
- Colorectal cancer test kit
- DNA extraction assay kit
- FFPE tissues assay kit
- Digital detection kit
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.